Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH

NCT00588536 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Methotrexate
DRUG: 6-Thioguanine
DRUG: Leucovorin Calcium

Sponsor

Memorial Sloan Kettering Cancer Center